"Sylvester Comprehensive Cancer Center is the only university-based comprehensive cancer center and only NCI-designated cancer center in the region. With more treatment options and more clinical trials than most hospitals in the southeastern United States, Sylvester is advancing cancer care in the region and beyond — all in pursuit of your cure. Teams of physicians and scientists work together to move discoveries from Sylvester's labs to patients and out into the community. As the home to South Florida's only Phase 1 Clinical Trials program, Sylvester offers novel treatments and hope to patients with rare forms of cancer."

During the past decade, UM Sylvester Comprehensive Cancer Center at Plantation conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 18 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 14 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Plantation" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Plantation" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "UM Sylvester Comprehensive Cancer Center at Plantation" are "Clinical Stage IV Cutaneous Melanoma AJCC v8" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials) and "Unresectable Melanoma" (4 trials). Many other conditions were trialed in "UM Sylvester Comprehensive Cancer Center at Plantation" in a lesser frequency.

Most popular intervention types in "UM Sylvester Comprehensive Cancer Center at Plantation" are "Drug" (64 trials), "Other" (39 trials), "Procedure" (35 trials), "Biological" (33 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (20 trials), "Computed Tomography" (18 trials), "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (16 trials) and "Nivolumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "UM Sylvester Comprehensive Cancer Center at Plantation" are 67 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UM Sylvester Comprehensive Cancer Center at Plantation". undefined are not yet recruiting, 32 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in UM Sylvester Comprehensive Cancer Center at Plantation, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UM Sylvester Comprehensive Cancer Center at Plantation, 8 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".